The import value of rye ergot alkaloids to the US is forecasted to decline steadily from 2024 to 2028. Starting at 4.1111 million USD in 2024, the value is expected to drop to 2.6893 million USD by 2028. This reflects a consistent downward trend with a negative year-on-year growth, highlighting shrinking import demand or potential shifts in supply. The compound annual growth rate (CAGR) over these five years indicates an average decline, suggesting persistent long-term contraction.
Future trends to watch for include potential impacts of regulatory changes, shifts in domestic production, and evolving pharmaceutical demands that might alter the importation landscape of rye ergot alkaloids.
